sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks BIA 10-2474

BIA 10-2474

CAS No.:
1233855-46-3
Catalog Number:
AG000KGU
Molecular Formula:
C16H20N4O2
Molecular Weight:
300.3556
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
1 week
United States
$140
- +
10mg
98%
1 week
United States
$203
- +
25mg
≥98%
1 week
United States
$501
- +
50mg
98%
1 week
United States
$578
- +
100mg
98%
1 week
United States
$862
- +
Product Description
Catalog Number:
AG000KGU
Chemical Name:
BIA 10-2474
CAS Number:
1233855-46-3
Molecular Formula:
C16H20N4O2
Molecular Weight:
300.3556
MDL Number:
MFCD30532661
IUPAC Name:
N-cyclohexyl-N-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide
InChI:
InChI=1S/C16H20N4O2/c1-18(14-7-3-2-4-8-14)16(21)19-11-15(17-12-19)13-6-5-9-20(22)10-13/h5-6,9-12,14H,2-4,7-8H2,1H3
InChI Key:
DOWVMJFBDGWVML-UHFFFAOYSA-N
SMILES:
[O-][n+]1cccc(c1)c1ncn(c1)C(=O)N(C1CCCCC1)C
UNII:
5AP1ZW859M
Properties
Complexity:
386  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
300.159g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
300.362g/mol
Monoisotopic Mass:
300.159g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
63.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.3  
Literature
Title Journal
Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase. ChemMedChem 20181022
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. Science (New York, N.Y.) 20170609
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014). Expert opinion on therapeutic patents 20150101
The endocannabinoid system as a potential therapeutic target for pain modulation. Balkan medical journal 20140601
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20140214
Properties